Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Guardian Pharmacy Services, Inc. (GRDN) Cash Flow Statement

Guardian Pharmacy Services, Inc. (GRDN) generated $98.9M of operating cash flow over the twelve months to 2026-06-30, spent $23.6M on capital expenditure and had free cash flow of $75.3M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

GRDNGuardian Pharmacy Services, Inc.Follow GRDN — free
Medical Care Facilities · Healthcare
—
Price chart with a free account
Market cap
2.5B
P/E TTM
38.7
Dividend yield
—
52-week
—
Next earnings
17 Nov, in 24 days
LineFY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow0.060.100.10
Capital expenditure0.030.03-0.02
Free cash flow0.030.070.08
Stock-based compensation0.130.01—

USD billions · SEC XBRL

Guardian Pharmacy Services, Inc. — questions

What is Guardian Pharmacy Services, Inc.'s operating cash flow?
$98.9M over the twelve months to 2026-06-30.
How much does Guardian Pharmacy Services, Inc. spend on capital expenditure?
$23.6M over the twelve months to 2026-06-30.
What is Guardian Pharmacy Services, Inc.'s free cash flow?
$75.3M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from Guardian Pharmacy Services, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.